Factors affecting the diagnosis of prostate cancer through 12 quadrant guided prostate biopsy

References

• Jhan JH, Yang YH, Chang YH, et al. Hormone therapy for prostate cancer increases the risk of Alzheimer’s disease: a nationwide 4-year longitudinal cohort study. Aging Male. 2017;20:33–38.
   PubMed Web of Science ®Google Scholar
• Mettlin CJ, Murphy GP. Why is the prostate cancer death rate declining in the United States? Cancer. 1998;82:249–251.
   PubMed Web of Science ®Google Scholar
• Astraldi A. Diagnosis of cancer of the prostate: biopsy by rectal route. Urol Cutan Rev. 1937;41:421–427.
   Google Scholar
• Matlaga BR, Eskew LA, McCullough DL. Prostate biopsy: indications and technique. J Urol. 2003;169:12–19.
   PubMed Web of Science ®Google Scholar
• Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of prostate. J Urol. 1989;142:71–74.
   PubMed Web of Science ®Google Scholar
• Norberg M, Egevad L, Holmberg L, et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997;50:562–566.
   PubMed Web of Science ®Google Scholar
• Babaian RJ, Toi A, Kamoi K, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol. 2000;163:152–157.
   PubMed Web of Science ®Google Scholar
• Collins GN, Lloyd SN, Hehir M, et al. Multiple transrectal ultrasound guided prostatic biopsies; true morbidity and patient acceptance. Br J Urol. 1993;71:460–463.
   PubMedGoogle Scholar
• Chappell B, McLoughlin J. Technical considerations when obtaining and interpreting prostatic biopsies from men with suspicion of early prostate cancer: part I. BJU Int. 2005;95:1135–1140.
   PubMed Web of Science ®Google Scholar
• Aus G, Hermansson CG, Hugosson J, et al. Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol. 1993;71:457–459.
   PubMedGoogle Scholar
• Gustafsson O, Norming U, Nyman CR, et al. Complications following transrectal aspiration and core biopsy of the prostate. Scand J Urol Nephrol. 1990;24:249–251.
   PubMedGoogle Scholar
• Tienza, A, Robles JE, Hevia M, et al. Prevalence analysis of urinary incontinence after radical prostatectomy and influential preoperative factors in a single institution. Aging Male. 2018;21:24–30.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Kim SJ, Kim YB, et al. Radical prostatectomy for clinically localized prostate cancer in patients aged 75 years or older: comparison with primary androgen deprivation therapy. Aging Male. 2018;21:17–23.
   PubMed Web of Science ®Google Scholar
• Chen ME, Johnston DA, Tang K, et al. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer. 2000;89:1800–1809.
   PubMed Web of Science ®Google Scholar
• Eskicorapci SY, Baydar DE, Akbal C, et al. An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer. Eur Urol. 2004; 45:444–448.
   PubMed Web of Science ®Google Scholar
• Presti JC, Jr, O’Dowd GJ, Miller MC, et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol. 2003;169:125–129.
   PubMed Web of Science ®Google Scholar
• Okihara K, Kojima M, Nakanouchi T, et al. Transrectal power Doppler imaging in the detection of prostate cancer. BJU Int. 2000;85:1053–1057.
   PubMed Web of Science ®Google Scholar
• Raja J, Ramachandran N, Munneke G, et al. Current status of transrectal ultrasoud-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol. 2006;61:142–153.
   PubMed Web of Science ®Google Scholar
• Davis M, Sofer M, Kim SS, et al. The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol. 2002;167:566–570.
   PubMed Web of Science ®Google Scholar
• Galetti TP, Dal Moro F, Milani C, et al. Patient’s preparation in order to reduce pain, anxiety and complications of TRUS prostatic biopsies. Eur Urol. 2002;1:3–7.
   Web of Science ®Google Scholar
• Haas GP, Delongchamps N, Brawley OW, et al. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol. 2008;15:3866–3871.
   PubMed Web of Science ®Google Scholar
• Eskicorapci SY, Guliyev F, Islamoglu E, et al. The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14-core prostate biopsy technique. Int Urol Nephrol. 2007;39:189–195.
   PubMed Web of Science ®Google Scholar
• Raviv G, Zlotta AR, Janssen T, et al. Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma? Cancer. 1996;77:2103–2108.
   PubMed Web of Science ®Google Scholar
• Xu B, Min Z, Cheng G, et al. Evaluating possible predictors of prostate cancer to establish a scoring system for repeat biopsies in Chinese men. J Ultrasound Med. 2011;30:503–508.
   PubMed Web of Science ®Google Scholar
• Ukimura O, Durrani O, Babaian RJ. Role of PSA and its indices in determining the need for repeat prostate biopsies. Urology. 1997;50:66–72.
   PubMed Web of Science ®Google Scholar
• Rietbergen JB, Kruger AE, Hoedemaeker RF, et al. Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer. J Urol. 1998;160:2121–2125.
   PubMed Web of Science ®Google Scholar
• Djavan B, Zlotta A, Remzi M, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol. 2000;163:1144–1148.
   PubMed Web of Science ®Google Scholar
• Levine MA, Ittman M, Melamed J, et al. Two consecutive sets of transrectal ultrasoundguided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159:471–475.
   PubMed Web of Science ®Google Scholar
• Djavan B, Zlotta AR, Remzi M, et al. Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection? Urology. 1999;54:846–852.
   PubMed Web of Science ®Google Scholar
• Vashi AR, Wojno KJ, Gillespie B, et al. A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol. 1998;159:920–924.
   PubMed Web of Science ®Google Scholar
• Remzi M, Fong YK, Dobrovits M, et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol. 2005;174:1256–1260.
   PubMed Web of Science ®Google Scholar
• Russo GI, Di Mauro M, Regis F, et al. Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily. Aging Male. 2018;21(1):48–54.
   PubMed Web of Science ®Google Scholar
• Ohwaki K, Endo F, Shimbo M, et al. Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer. Aging Male. 2017;20:257–260.
   PubMed Web of Science ®Google Scholar
• Yassin A, Salman M, Talib RA, et al. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register. Aging Male. 2017;20:125–133.
   PubMed Web of Science ®Google Scholar